Boston Scientific Corp (BSX)

$69.48 -0.41 (-0.59%)
Market Cap 103.26B
Revenue (ttm) 20.07B
Net Income (ttm) 2.90B
EPS (ttm) N/A
PE Ratio 22.91
Forward PE 20.24
Profit Margin 14.44%
Debt to Equity Ratio 0.47
Volume 20,129,700
Avg Vol 16,210,521
Day's Range N/A - N/A
Shares Out 1.49B
Stochastic %K 44%
Beta 0.69
Analysts Strong Sell
Price Target $105.94

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary syst...

Industry: Medical Devices
Sector: Healthcare
Phone: 508 683 4000
Address:
300 Boston Scientific Way, Marlborough, United States
BioTechHealthX
BioTechHealthX Mar. 21 at 4:00 AM
$BSX Boston Scientific (NYSE:BSX) may be down, but analysts believe the pullback is overdone. With strong growth, innovative medical devices, and rising demand, this healthcare stock could be setting up for a rebound. https://biotechhealthx.com/biotech-news/heres-why-should-start-investing-in-boston-scientific-bsx/
0 · Reply
DragonAlgo
DragonAlgo Mar. 20 at 11:04 PM
🐉 $BSX PUT — DragonAlgo® Signal Contract: BSX PUT Expiry: 2026-03-20 | Strike: $80.00 | Type: PUT Option Plan (premium): Entry: $10.50 Stop: $7.56 TP1: $13.65 TP2: $17.85 TP3: $25.20 🔗 https://dragonalgo.com
0 · Reply
Bazzzigar
Bazzzigar Mar. 20 at 3:34 PM
$BSX ABT
0 · Reply
amberajax2point0
amberajax2point0 Mar. 20 at 2:52 PM
$BSX a little life
0 · Reply
DragonAlgo
DragonAlgo Mar. 20 at 4:33 AM
🐉 $BSX PUT — DragonAlgo® Signal Contract: BSX PUT Expiry: 2026-03-20 | Strike: $80.00 | Type: PUT Option Plan (premium): Entry: $10.30 Stop: $7.42 TP1: $13.39 TP2: $17.51 TP3: $24.72 🔗 https://dragonalgo.com
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 19 at 9:06 PM
Sold $BSX at $70.37 (-1%). From Grok: "" https://www.techtrader.ai/grokwall/?post=17115&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
MHM7700
MHM7700 Mar. 19 at 5:55 PM
160% gains locked in on the $BSX puts. Scaling out heavy here. https://www.stocktwits.com/MHM7700/message/647984125
0 · Reply
vastav
vastav Mar. 19 at 5:48 PM
$BSX good stock for entry. Under 70 is good.
0 · Reply
Fullport0dtexx
Fullport0dtexx Mar. 19 at 5:33 PM
$BSX scalp
0 · Reply
Fullport0dtexx
Fullport0dtexx Mar. 19 at 5:28 PM
$BSX rsi at 19
0 · Reply
Latest News on BSX
Invesco Summit Fund Q4 2025 Portfolio Positioning

Mar 17, 2026, 2:42 PM EDT - 4 days ago

Invesco Summit Fund Q4 2025 Portfolio Positioning

AMD BX FN KKR ORCL

BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt

Mar 12, 2026, 9:00 AM EDT - 9 days ago

BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt

8 Stocks to Buy as Merger-Mania Takes Over

Mar 10, 2026, 12:42 PM EDT - 11 days ago

8 Stocks to Buy as Merger-Mania Takes Over

AVTR EPC ITGR MXL PEN POWI PRGO

BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm

Mar 8, 2026, 8:24 PM EDT - 13 days ago

BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm

BOSTON SCIENTIFIC CORPORATION (BSX) INVESTOR ALERT Investors With Large Losses in Boston Scientific Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Mar 6, 2026, 1:56 PM EST - 15 days ago

BOSTON SCIENTIFIC CORPORATION (BSX) INVESTOR ALERT Investors With Large Losses in Boston Scientific Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology

Mar 6, 2026, 8:00 AM EST - 15 days ago

Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology

Boston Scientific Corporation Investigated by the Portnoy Law Firm

Mar 4, 2026, 9:00 AM EST - 17 days ago

Boston Scientific Corporation Investigated by the Portnoy Law Firm

Boston Scientific Corporation (BSX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 3, 2026, 12:12 PM EST - 18 days ago

Boston Scientific Corporation (BSX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Baron Health Care Fund Q4 2025 Recent Activity

Mar 3, 2026, 10:36 AM EST - 18 days ago

Baron Health Care Fund Q4 2025 Recent Activity

ACLX ARQT ELAN MASI RGEN SYK TMO

Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 25, 2026, 1:00 PM EST - 24 days ago

Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

PEN

Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors

Feb 23, 2026, 8:00 AM EST - 26 days ago

Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors

Back on the Radar: Prior Picks Offer Fresh Opportunity

Feb 18, 2026, 10:47 AM EST - 4 weeks ago

Back on the Radar: Prior Picks Offer Fresh Opportunity

NFLX

Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

Feb 13, 2026, 8:00 AM EST - 5 weeks ago

Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

Reassessing The Boston Scientific Bull Thesis

Feb 6, 2026, 2:05 PM EST - 6 weeks ago

Reassessing The Boston Scientific Bull Thesis

What Happened To Boston Scientific Stock?

Feb 5, 2026, 2:25 PM EST - 6 weeks ago

What Happened To Boston Scientific Stock?

Boston Scientific Analysts Cut Their Forecasts Following Q4 Results

Feb 5, 2026, 8:18 AM EST - 6 weeks ago

Boston Scientific Analysts Cut Their Forecasts Following Q4 Results

Boston Scientific Corporation (BSX) Q4 2025 Earnings Call Transcript

Feb 4, 2026, 3:30 PM EST - 6 weeks ago

Boston Scientific Corporation (BSX) Q4 2025 Earnings Call Transcript

Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Feb 4, 2026, 9:19 AM EST - 6 weeks ago

Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply.

Feb 4, 2026, 8:12 AM EST - 6 weeks ago

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply.

Boston Scientific shares slide on cautious 2026 revenue forecast

Feb 4, 2026, 8:02 AM EST - 6 weeks ago

Boston Scientific shares slide on cautious 2026 revenue forecast

Boston Scientific announces results for fourth quarter and full year 2025

Feb 4, 2026, 6:30 AM EST - 6 weeks ago

Boston Scientific announces results for fourth quarter and full year 2025

PEN

Boston Scientific Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Feb 4, 2026, 2:02 AM EST - 6 weeks ago

Boston Scientific Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)

Feb 2, 2026, 5:02 PM EST - 6 weeks ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)

Artisan Global Opportunities Fund Q4 2025 Portfolio Update

Jan 29, 2026, 9:39 AM EST - 7 weeks ago

Artisan Global Opportunities Fund Q4 2025 Portfolio Update

ARGX BKR COF COIN INSM LEG LHX

Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage

Jan 26, 2026, 2:54 PM EST - 7 weeks ago

Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage

APP CMI MNST WYNN

Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio Activity

Jan 22, 2026, 12:05 AM EST - 2 months ago

Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio Activity

ADBE AMZN AON MELI SAP SPOT

How Low Can Boston Scientific Stock Go When Markets Turn Sour?

Jan 16, 2026, 10:00 AM EST - 2 months ago

How Low Can Boston Scientific Stock Go When Markets Turn Sour?

Boston Scientific Corporation (BSX) M&A Call Transcript

Jan 15, 2026, 12:05 PM EST - 2 months ago

Boston Scientific Corporation (BSX) M&A Call Transcript

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

Jan 15, 2026, 11:03 AM EST - 2 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach

Jan 15, 2026, 9:11 AM EST - 2 months ago

Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach

PEN

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.

Jan 15, 2026, 8:45 AM EST - 2 months ago

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.

PEN

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments

Jan 15, 2026, 8:11 AM EST - 2 months ago

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments

PEN

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

Jan 15, 2026, 7:19 AM EST - 2 months ago

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

PEN

Boston Scientific to buy Penumbra in deal valued at $14.5 billion

Jan 15, 2026, 7:07 AM EST - 2 months ago

Boston Scientific to buy Penumbra in deal valued at $14.5 billion

PEN

Boston Scientific announces agreement to acquire Penumbra, Inc.

Jan 15, 2026, 7:00 AM EST - 2 months ago

Boston Scientific announces agreement to acquire Penumbra, Inc.

PEN

Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 3:55 PM EST - 2 months ago

Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

Jan 12, 2026, 7:00 AM EST - 2 months ago

Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

Jan 2, 2026, 8:00 AM EST - 2 months ago

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside

Dec 28, 2025, 2:40 AM EST - 2 months ago

Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside

Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript

Dec 2, 2025, 4:23 PM EST - 3 months ago

Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript

BioTechHealthX
BioTechHealthX Mar. 21 at 4:00 AM
$BSX Boston Scientific (NYSE:BSX) may be down, but analysts believe the pullback is overdone. With strong growth, innovative medical devices, and rising demand, this healthcare stock could be setting up for a rebound. https://biotechhealthx.com/biotech-news/heres-why-should-start-investing-in-boston-scientific-bsx/
0 · Reply
DragonAlgo
DragonAlgo Mar. 20 at 11:04 PM
🐉 $BSX PUT — DragonAlgo® Signal Contract: BSX PUT Expiry: 2026-03-20 | Strike: $80.00 | Type: PUT Option Plan (premium): Entry: $10.50 Stop: $7.56 TP1: $13.65 TP2: $17.85 TP3: $25.20 🔗 https://dragonalgo.com
0 · Reply
Bazzzigar
Bazzzigar Mar. 20 at 3:34 PM
$BSX ABT
0 · Reply
amberajax2point0
amberajax2point0 Mar. 20 at 2:52 PM
$BSX a little life
0 · Reply
DragonAlgo
DragonAlgo Mar. 20 at 4:33 AM
🐉 $BSX PUT — DragonAlgo® Signal Contract: BSX PUT Expiry: 2026-03-20 | Strike: $80.00 | Type: PUT Option Plan (premium): Entry: $10.30 Stop: $7.42 TP1: $13.39 TP2: $17.51 TP3: $24.72 🔗 https://dragonalgo.com
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 19 at 9:06 PM
Sold $BSX at $70.37 (-1%). From Grok: "" https://www.techtrader.ai/grokwall/?post=17115&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
MHM7700
MHM7700 Mar. 19 at 5:55 PM
160% gains locked in on the $BSX puts. Scaling out heavy here. https://www.stocktwits.com/MHM7700/message/647984125
0 · Reply
vastav
vastav Mar. 19 at 5:48 PM
$BSX good stock for entry. Under 70 is good.
0 · Reply
Fullport0dtexx
Fullport0dtexx Mar. 19 at 5:33 PM
$BSX scalp
0 · Reply
Fullport0dtexx
Fullport0dtexx Mar. 19 at 5:28 PM
$BSX rsi at 19
0 · Reply
MHM7700
MHM7700 Mar. 19 at 2:47 PM
$BSX 0320 70p $ 0.45
0 · Reply
DragonAlgo
DragonAlgo Mar. 19 at 1:52 PM
🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-03-20 | Strike: $71.00 | Type: CALL Option Plan (premium): Entry: $1.09 Stop: $0.78 TP1: $1.42 TP2: $1.85 TP3: $2.62 Momentum tape remains active. 🔗 https://dragonalgo.com
0 · Reply
BioTechHealthX
BioTechHealthX Mar. 18 at 5:10 PM
$AZN $BSX $GILD $PFE $TMO While AI stocks dominate headlines, healthcare stocks are silently outperforming the S&P 500. Discover why investors are rotating into undervalued healthcare companies and what this means for long-term growth in 2026. https://biotechhealthx.com/biotech-news/top-10-healthcare-stocks-according-to-goldman-sachs/
0 · Reply
danielwww
danielwww Mar. 18 at 12:41 AM
$BSX here we go 💰
0 · Reply
Bazzzigar
Bazzzigar Mar. 18 at 12:16 AM
$BSX Finally
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 17 at 8:07 PM
Bought $BSX at $71.11. From Grok: "Although we stayed in cash yesterday due to the continued downtrend and repeated failed bounces, today's strong follow-through to 71.18 on the third straight up day shifts the picture enough to go long now. " https://www.techtrader.ai/grokwall/?post=17019&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
DragonAlgo
DragonAlgo Mar. 17 at 7:25 PM
🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-03-20 | Strike: $70.00 | Type: CALL Option Plan (premium): Entry: $1.85 Stop: $1.33 TP1: $2.41 TP2: $3.15 TP3: $4.44 Volatility regime is active. 🔗 https://dragonalgo.com
0 · Reply
DiamondCapital
DiamondCapital Mar. 17 at 2:22 PM
$CVKD Insane board for 18M MC company •Lee Golden, Executive VP and CMO at $PTCT ($5.6B MC), former CMO at $ESPR ($698M MC) •Steven Zelenkofske, held leadership positions at $BSX, $NVS, AZN •John Murphy director at ORLY & APR which was acquired by OMI for $1.6B
1 · Reply
Ingo420
Ingo420 Mar. 17 at 9:31 AM
$BSX @Stocktwits @StocktwitsEarnings @Cryptotwits when will you do something about the bots you fuckers?
0 · Reply
Ingo420
Ingo420 Mar. 17 at 9:08 AM
$BSX $COF $ETN $PGR @Stocktwits @StocktwitsEarnings @Cryptotwits when will you do something about the bots you fuckers?
1 · Reply
prismmarketview
prismmarketview Mar. 16 at 4:05 PM
$BSX Boston Scientific Secures Strategic Manufacturing License to Lead China’s Medtech Market https://prismmarketview.com/boston-scientific-secures-strategic-manufacturing-license-to-lead-chinas-medtech-market/
0 · Reply
DragonAlgo
DragonAlgo Mar. 16 at 8:42 AM
🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-03-20 | Strike: $72.50 | Type: CALL Option Plan (premium): Entry: $0.42 Stop: $0.30 TP1: $0.55 TP2: $0.71 TP3: $1.01 🔗 https://dragonalgo.com
0 · Reply